Events

Exploring the dynamics, legalities and hurdles in a period of transition for Parallel Trade

4 - 5 February 2020, London, UK.
SMi presents Europe's leading 14th annual Parallel Trade conference, taking place in London. As the only B2B parallel trade conference in Europe, this event provides the perfect platform for industry experts from both sides of the coin to come together and share perspectives on the practice of parallel trade.

RNA Therapeutics Conference and Focus Day

19 - 20 February 2020, London, UK.
The field of RNA therapeutics is rapidly expanding, and the potential for using RNA drugs for personalised medicines and immunotherapy, as well as to address genetic, infectious and chronic diseases will ensure the continued development of RNA therapeutics for years to come.

CPhI Worldwide announces the winners of the 16th Pharma Awards

5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide, organised by Informa PLC, announced the winners of the prestigious 2019 CPhI Pharma Awards - celebrating the industry's top innovators, performers and outstanding achievements across 13 categories, spanning the entire industry supply chain. The winners have been recognised for delivering excellence in pharma and were unveiled during a ceremony on the opening evening of CPhI Worldwide in Frankfurt.

CPhI Annual Report predicts Europe to surpass the USA in biologic manufacturing capacity by 2023

5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide - the world's largest pharma event, taking place in Frankfurt, Germany - released the second part of its annual report focussed on biologicals.

Fittingly, in 2019 BioProduction - which features five concurrent streams of content covering the entire spectrum of biopharmaceutical development and production - will run alongside CPhI Worldwide for the first time, bringing together the entire pharma and biopharma supply chain.

SMi's 9th Annual Pharmaceutical Microbiology UK Conference

20 - 21 January 2020, London, UK.
Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

'FDA should withdraw ANDAs', and 'new technologies could bring massive improvements in efficiency' if implemented correctly

5 - 7 November 2019, Frankfurt, Germany.
CPhI Worldwide - the world's largest pharma event taking place in Frankfurt - has released the first part of its eponymous 2019 Annual Report. Experts Bikash Chatterjee, President and Chief Science Officer at Pharmtech Associates and Girish Malhotra, President of EPCOT International discuss how manufacturing could be revolutionised by new technologies, but warn, that regulators must change to prevent hindering future innovation.

SMi's 9th Annual Orphan Drugs & Rare Diseases Conference

15 - 16 October 2019, London, UK.
The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs - this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.

Events

More Pharma News ...